Leitlinien Play Pause Unmute Mute AG Radiopharmaka Positionspapier der OGNMB zu Bezug und Herstellung von radioaktiven Arzneimitteln Positionspapier der OGNMB zur Herstellung und Qualitätskontrolle von radioaktiven Arzneimitteln (Radiopharmaka) in österreichischen nuklearmedizinischen Institutionen und Laboratorien gemäß §62, AMG i.d.g.F. Positionspapier der OGNMB zur Herstellung von 68Ga-Radiopharmaka AG Nuklearmedizinische Hybridbildgebung Positionspapier zur Hybrid-Bildgebung (2017) 18F-NaF PET/CT: EANM procedure guidelines for bone imaging (2015) SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 (2016) Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring (2017) 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 (2017) Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 (2018) EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma (2019) SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0 (2020) Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (2017)